Illustrative image – not actual.
Indoco Remedies has received an approval from the US Food and Drug Administration (USFDA) for its solid dosages manufacturing facility at Goa (Plant I).
The plant has a capacity to manufacture 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and ointments, and 60 million capsules of hard gelatin.
Apart from the USFDA's approval, the plant is also approved by the UK-MHRA, MCC-South Africa, TGA-Australia and ANVISA-Brazil.
